Steve Harr
President & CEO · Sana Biotechnology, Inc.
Individual
- 2026
- Mar 10, 2026
- 2
Filings (90d)
0
Other insiders active in the same sector
No other insider has filed at Steve Harr's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $69.43M in VOR purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steve Harr?
Steve Harr is a corporate insider, tracked as President & CEO of Sana Biotechnology, Inc. (SANA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Steve Harr last file a Form 4?
The most recent primary Form 4 on record is dated 10 March 2026, one of 2 filings going back to 2026.
